These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 25131876)

  • 41. Carcinoid heart disease: current understanding and future directions.
    Patel C; Mathur M; Escarcega RO; Bove AA
    Am Heart J; 2014 Jun; 167(6):789-95. PubMed ID: 24890526
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Regression of metastatic carcinoid tumors with octreotide therapy: two case reports and a review of the literature.
    Leong WL; Pasieka JL
    J Surg Oncol; 2002 Mar; 79(3):180-7. PubMed ID: 11870669
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Multidisciplinary treatment of advanced thymic neuroendocrine carcinoma (carcinoid): report of a successful case and review of the literature.
    Filosso PL; Actis Dato GM; Ruffini E; Bretti S; Ozzello F; Mancuso M
    J Thorac Cardiovasc Surg; 2004 Apr; 127(4):1215-9. PubMed ID: 15052231
    [No Abstract]   [Full Text] [Related]  

  • 44. Octreotide LAR Dosage and Survival Among Elderly Patients With Distant-Stage Neuroendocrine Tumors.
    Shen C; Xu Y; Dasari A; Shih YC; Yao JC
    Oncologist; 2016 Mar; 21(3):308-13. PubMed ID: 26911407
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Sandostatin desensitization--a strategy useful for patients with carcinoid tumors, intolerant to sandostatin.
    Vinjamaram S; Iyer R
    Cancer Chemother Pharmacol; 2011 Jul; 68(1):225-6. PubMed ID: 20922390
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Recurrent thymic carcinoid tumor with multiple endocrine neoplasia syndrome--a case report].
    Kanno R; Yanai K; Ohishi A; Noue H; Motoki R
    Nihon Kyobu Geka Gakkai Zasshi; 1997 Feb; 45(2):213-9. PubMed ID: 9071147
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Bronchial and Thymic Carcinoid Tumors.
    Litvak A; Pietanza MC
    Hematol Oncol Clin North Am; 2016 Feb; 30(1):83-102. PubMed ID: 26614370
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Thymic carcinoid in association with MEN syndromes.
    Zeiger MA; Swartz SE; MacGillivray DC; Linnoila I; Shakir M
    Am Surg; 1992 Jul; 58(7):430-4. PubMed ID: 1352092
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A clinical overview of carcinoid tumors: perspectives for improvement in treatment using peptide analogs (review).
    Comaru-Schally AM; Schally AV
    Int J Oncol; 2005 Feb; 26(2):301-9. PubMed ID: 15645113
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Management of malignant tumors of the thymus].
    Tubota N; Yamashita C; Ishii N; Yoshikawa K; Aogauchi R; Yasuoka S; Nakamura K
    Nihon Geka Gakkai Zasshi; 1985 Jun; 86(6):752-61. PubMed ID: 2993845
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Long-term survival of atypical bronchial carcinoids with liver metastases, treated with octreotide.
    Filosso PL; Ruffini E; Oliaro A; Papalia E; Donati G; Rena O
    Eur J Cardiothorac Surg; 2002 May; 21(5):913-7. PubMed ID: 12062286
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [An ACTH-secreting carcinoid tumor of the thymus. A report of a new case].
    Muñoz Ruiz AI; Calvo Elipe A; Llorente Herrero E; Guerrero Vega E; Pato Alonso S; Rodríguez Dorrego R; Gilsanz Fernández C
    An Med Interna; 1995 Apr; 12(4):189-91. PubMed ID: 7620065
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Thymic carcinoid tumor--a report of 7 cases.
    Zhang Z; Ren H; Yu H; Li Z; Liu H; Lu Z
    Chin Med Sci J; 1993 Mar; 8(1):48-51. PubMed ID: 8274723
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Gastrointestinal carcinoid tumors: diagnosis and treatment.
    Stamatakos M; Kontzoglou K; Sargedi C; Tsaknaki S; Iannescu R; Safioleas C; Kaitanidi V; Safioleas M
    Chirurgia (Bucur); 2010; 105(6):759-66. PubMed ID: 21351698
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Recurrent thymic carcinoid tumor in the pleural cavity. 2 cases of long-term survivors.
    Tsuchida M; Yamato Y; Hashimoto T; Saito M; Hayashi J
    Jpn J Thorac Cardiovasc Surg; 2001 Nov; 49(11):666-8. PubMed ID: 11757339
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Long-term survival in a patient with malignant carcinoid treated with high-dose octreotide.
    Deguchi H; Deguchi K; Tsukada T; Murashima S; Iwasaki E; Tsuda M; Kobayashi T; Shirakawa S
    Intern Med; 1994 Feb; 33(2):100-2. PubMed ID: 7517229
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Treatment of liver metastases of carcinoid tumors.
    Ahlman H; Westberg G; Wängberg B; Nilsson O; Tylén U; Scherstén T; Tisell LE
    World J Surg; 1996 Feb; 20(2):196-202. PubMed ID: 8661817
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Long-term survival and nearly asymptomatic course of carcinoid tumour with multiple metastases (treated by surgery, chemotherapy, (90)Y-DOTATATE, and LAR octreotide analogue): a case report.
    Kałuzny M; Bolanowski M; Sukiennik-Kujawa M; Ponikowski P; Handkiewicz-Junak D; Jarzab B; Jawiarczyk A; Syrycka J
    Endokrynol Pol; 2009; 60(5):401-6. PubMed ID: 19885812
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Efficacy of octreotide in the regression of a metastatic carcinoid tumour despite negative imaging with In-111-pentetreotide (Octreoscan).
    Hillman N; Herranz L; Alvarez C; Martínez Olmos MA; Márco A; Gómez-Pan A
    Exp Clin Endocrinol Diabetes; 1998; 106(3):226-30. PubMed ID: 9710364
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Update on carcinoid syndrome.
    Melnyk DL
    AANA J; 1997 Jun; 65(3):265-70. PubMed ID: 9233098
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.